Johnson & Johnson (JNJ) has received FDA De Novo authorization for its OTTAVA robotic surgical system, officially entering the U.S. soft-tissue market where Intuitive Surgical (ISRG) currently dominates. The OTTAVA platform features a unique table-integrated architecture that occupies 30% to 50% less space than traditional...
Alamar Capital Management LLC acquired a new stake in Intuitive Surgical, Inc. (ISRG) during the first quarter, purchasing 3,563 shares valued at approximately $1.64 million. This filing highlights continued institutional interest alongside other funds like Fiduciary Financial Group and North Star Investment Management, which increased...
Shares of Intuitive Surgical (NASDAQ:ISRG) hit a new 52-week low around $346 on Monday, driven by JPMorgan Chase lowering its price target from $550 to $450 while maintaining an overweight rating. The stock has faced mixed analyst sentiment recently, with Deutsche Bank cutting its target...
Intuitive Surgical (NASDAQ:ISRG) faces a mixed analyst outlook following a cluster of price target reductions from major brokerages on Friday. Citigroup lowered its target from $590 to $500, while BTIG Research, Robert W. Baird, and Sanford C. Bernstein also cut their targets to $469, $500,...
Aaron Wealth Advisors LLC reduced its stake in Intuitive Surgical, Inc. (ISRG) by 21.9% in the first quarter, selling 1,377 shares and holding a remaining position of 4,903 shares valued at $2.26 million. This move was part of broader institutional activity where other firms like...
